Results 121 to 130 of about 2,680 (197)

Emergence and dissemination of multidrug-resistant Klebsiella pneumoniae harboring the novel tmexCD-toprJ RND efflux pump operon

open access: yesFrontiers in Cellular and Infection Microbiology
The global emergence of multidrug-resistant (MDR) Klebsiella pneumoniae, particularly carbapenem-resistant K. pneumoniae (CRKP), presents a severe public health threat, limiting available treatment options.
Haojin Gao   +10 more
doaj   +1 more source

Outer membrane vesicles of carbapenem-resistant clinical Acinetobacter baumannii isolates protect both the vesicle-producing bacteria and non-resistant bacteria against carbapenems [PDF]

open access: yes
Infections caused by carbapenem-resistant Acinetobacter baumannii (A. baumannii; CRAb) are associated with high patient morbidity and mortality. The serious threat for human health imposed by CRAb was recently underscored by identification of close-to ...
Alcantud, Beatriz Santamarina   +8 more
core   +2 more sources

In Vitro Activities of Cefiderocol, Ceftazidime–Avibactam, Meropenem–Vaborbactam, Imipenem–Relebactam and Eravacycline Against Carbapenem-Resistant Klebsiella pneumoniae

open access: yesJournal of Global Antimicrobial Resistance
AIM/BACKGROUND: Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections are a significant global threat due to the limited treatment options. In this study, in vitro activities of novel antimicrobial agents were investigated against CRKP strains ...
FATMA SENA TÜRKDOĞAN, Betigul Ongen
doaj   +1 more source

Clinical outcomes and safety of eravacycline in hematology: a multicenter, real-world study. [PDF]

open access: yesAntimicrob Agents Chemother
Wang J   +8 more
europepmc   +1 more source

Eravacycline: From broad-spectrum coverage to novel clinical applications. [PDF]

open access: yesRev Esp Quimioter
Albanell-Fernández M   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy